| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $18.6B | $18.9B | $21.2B | $19.4B | $20.6B | $22.4B | $23.3B |
| Cost of Revenue | $16.6B | $13.4B | $13.6B | $15.1B | $13.8B | $14.4B | $15.3B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0B | $1.8B | $1.4B | $1.3B | $1.4B | $1.5B | $1.6B | $1.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-2.4B | $0.6B | $0.3B | $-0.3B | $0.1B | $0.2B | $0.2B | $0.3B |
| EPS (Basic) | $-4.52 | $1.60 | $0.83 | $-0.90 | $0.28 | $0.39 | $0.42 | $0.79 |
| EPS (Diluted) | $-4.52 | $1.57 | $0.82 | $-0.90 | $0.28 | $0.39 | $0.42 | $0.78 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $38.0B | $22.8B | $23.3B | $23.9B | $25.2B | $31.7B | $33.5B | $33.6B |
| Current Assets | $10.1B | $6.4B | $6.6B | $6.8B | $7.1B | $11.2B | $6.6B | $7.0B |
| Cash & Equivalents | $1.1B | — | — | — | — | — | $0.5B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.9B | $4.3B | $4.0B | $5.0B | $4.1B | $8.3B | $8.6B | $4.7B |
| Stockholders' Equity | $14.8B | — | — | — | $9.1B | $7.9B | $7.7B | $7.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.7B | $1.8B | $2.2B | $2.0B | $3.1B | $3.6B | $3.2B |
| Investing Cash Flow | $-1.0B | $-0.8B | $-0.7B | $-0.6B | $6.1B | $-0.3B | $-1.3B | $-1.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-0.8B | $-0.9B | $-2.1B | $-7.4B | $-2.7B | $-2.4B | $-2.0B |